AutoNation Institute for Breast Cancer Research and Care
AutoNation and racing champion, Ryan Hunter-Reay, endowed NSU’s AutoNation Institute for Breast Cancer Research and Care which is focused on developing microRNA drugs to address treatment resistance and reducing environmental risks of breast cancer by addressing ancestry-specific vulnerabilities. In addition we are developing new biomarkers to predict which early stage tumors will recur in the context of Nucleotide Excision Repair. The ultimate goal is translating the discoveries from the lab into clinical progress at the bedside.
NSU’s AutoNation Institute for Breast Cancer Research and Care is housed in the university’s Center for Collaborative Research (CCR), one of the largest (215,000 sq. ft.) and most advanced research facilities in Florida, with state-of-the-art laboratories.
Our focus is:
- evaluating the epigenetics of cancer cells and determining possible uses of microRNA to prevent drug resistance
- generating targeted cancer therapies based on genomics, transcriptomics and pharmacogenomics,
- testing chemicals included in consumer products to determine if there is a link to cancer, and educating the public and regulatory agencies of concerning findings
- using blood tests to check for biomarkers that indicate if a patient is predisposed to cancer and assessing whether patients will be responsive to chemotherapy
- establishing a Live Cell Bank that is focused on minority and underserved populations that are prevalent in South Florida
Visit the AutoNation website here.